Tue, July 26, 2011
Mon, July 25, 2011
Sat, July 23, 2011
Fri, July 22, 2011
Thu, July 21, 2011
Wed, July 20, 2011
[ Wed, Jul 20th 2011 ] - Market Wire
Pfizer To Acquire Icagen
[ Wed, Jul 20th 2011 ] - Market Wire
00 a.m. EDT
Tue, July 19, 2011
Mon, July 18, 2011
[ Mon, Jul 18th 2011 ] - Market Wire
Aetna to Acquire PayFlex
Fri, July 15, 2011
Thu, July 14, 2011
Wed, July 13, 2011
Tue, July 12, 2011
Mon, July 11, 2011
Sun, July 10, 2011
Sat, July 9, 2011
Fri, July 8, 2011
Thu, July 7, 2011
Wed, July 6, 2011
[ Wed, Jul 06th 2011 ] - Market Wire
Larry Renfro Named CEO of Optum
Tue, July 5, 2011
Mon, July 4, 2011
Sat, July 2, 2011
Fri, July 1, 2011
Thu, June 30, 2011
[ Thu, Jun 30th 2011 ] - Market Wire
KCI???NPWT????????????

Incyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical Programs on July 28


//health-fitness.news-articles.net/content/2011/ .. -update-on-key-clinical-programs-on-july-28.html
Published in Health and Fitness on Wednesday, July 13th 2011 at 13:25 GMT by Market Wire   Print publication without navigation


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, July 28, 2011. The schedules for the press release and conference call are as follows:

-- Q2 2011 Press Release: July 28, 2011 at 7:00 a.m. ET
-- Q2 2011 Conference Call: July 28, 2011 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 375487

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 375487.

The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].


Publication Contributing Sources